These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31808285)

  • 1. Is there any correlation between spectral CT imaging parameters and PD-L1 expression of lung adenocarcinoma?
    Chen ML; Shi AH; Li XT; Wei YY; Qi LP; Sun YS
    Thorac Cancer; 2020 Feb; 11(2):362-368. PubMed ID: 31808285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can spectral computed tomography imaging improve the differentiation between malignant and benign pulmonary lesions manifesting as solitary pure ground glass, mixed ground glass, and solid nodules?
    Chen ML; Li XT; Wei YY; Qi LP; Sun YS
    Thorac Cancer; 2019 Feb; 10(2):234-242. PubMed ID: 30582292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectral CT imaging parameters and Ki-67 labeling index in lung adenocarcinoma.
    Chen M; Li X; Wei Y; Qi L; Sun YS
    Chin J Cancer Res; 2020 Feb; 32(1):96-104. PubMed ID: 32194309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas.
    Yoon J; Suh YJ; Han K; Cho H; Lee HJ; Hur J; Choi BW
    Thorac Cancer; 2020 Apr; 11(4):993-1004. PubMed ID: 32043309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation with Spectral CT Imaging Parameters and Occult Lymph Nodes Metastases in Sufferers with Isolated Lung Adenocarcinoma.
    Liu Y; Nie Y
    Contrast Media Mol Imaging; 2022; 2022():5472446. PubMed ID: 35833081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression level of interleukin-1β is correlated with poor prognosis and PD-1 expression in patients with lung adenocarcinoma.
    Ding X; Zhang J; Shi M; Liu D; Zhang L; Zhang R; Su B; Ai K
    Clin Transl Oncol; 2021 Jan; 23(1):35-42. PubMed ID: 32472456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical importance of VEGFC and PD-L1 co-expression in lung adenocarcinoma patients.
    Qin T; Xia J; Liu S; Wang J; Liu H; Zhang Y; Jia Y; Li K
    Thorac Cancer; 2020 May; 11(5):1139-1148. PubMed ID: 32154654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors correlating the expression of PD-L1.
    Lu F; Wang E; Liu H
    BMC Cancer; 2024 May; 24(1):642. PubMed ID: 38796458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.
    Driver BR; Miller RA; Miller T; Deavers M; Gorman B; Mody D; Ge Y; Barrios R; Bernicker E; Kim M; Cagle PT
    Arch Pathol Lab Med; 2017 Nov; 141(11):1529-1532. PubMed ID: 28829153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma.
    Reiniger L; Téglási V; Pipek O; Rojkó L; Glasz T; Vágvölgyi A; Kovalszky I; Gyulai M; Lohinai Z; Rásó E; Tímár J; Döme B; Szállási Z; Moldvay J
    Acta Oncol; 2019 Aug; 58(8):1087-1094. PubMed ID: 31002007
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically resected pulmonary adenocarcinoma.
    Hu B; Xiao J; Xiu Y; Fu Z; Shi H; Cheng D
    Nucl Med Commun; 2020 Mar; 41(3):252-259. PubMed ID: 32068670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary exploration of the correlation between spectral computed tomography quantitative parameters and spread through air spaces in lung adenocarcinoma.
    Song H; Cui S; Zhang L; Lou H; Yang K; Yu H; Lin J
    Quant Imaging Med Surg; 2024 Jan; 14(1):386-396. PubMed ID: 38223127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association Between Imaging Features of TSCT and the Expression of PD-L1 in Patients With Surgical Resection of Lung Adenocarcinoma.
    Wu T; Zhou F; Soodeen-Lalloo AK; Yang X; Shen Y; Ding X; Shi J; Dai J; Shi J
    Clin Lung Cancer; 2019 Mar; 20(2):e195-e207. PubMed ID: 30514666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance Between Programmed Death Ligand 1 and Radiologic Invasiveness in Pathologic Stage I Lung Adenocarcinoma.
    Toyokawa G; Takada K; Okamoto T; Kawanami S; Kozuma Y; Matsubara T; Haratake N; Takamori S; Akamine T; Katsura M; Yamada Y; Shoji F; Baba S; Kamitani T; Oda Y; Honda H; Maehara Y
    Ann Thorac Surg; 2017 Jun; 103(6):1750-1757. PubMed ID: 28347537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid histological component of adenocarcinoma might play an important role in PD-L1 expression of lung adenocarcinoma.
    Miyazawa T; Morikawa K; Otsubo K; Sakai H; Kimura H; Chosokabe M; Furuya N; Marushima H; Kojima K; Mineshita M; Koike J; Saji H
    Thorac Cancer; 2022 Jan; 13(1):24-30. PubMed ID: 34811933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of immune checkpoint inhibitors according to PD-L1 tumor proportion scores in non-small cell lung cancer.
    Park S; Choi YD; Kim J; Kho BG; Park CK; Oh IJ; Kim YC
    Thorac Cancer; 2020 Feb; 11(2):408-414. PubMed ID: 31841269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional iodine mapping quantified by dual-energy CT for predicting programmed death-ligand 1 expression in invasive pulmonary adenocarcinoma.
    Yamagata K; Yanagawa M; Hata A; Ogawa R; Kikuchi N; Doi S; Ninomiya K; Tokuda Y; Tomiyama N
    Sci Rep; 2024 Aug; 14(1):18310. PubMed ID: 39112802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples.
    Zou Y; Xu L; Tang Q; You Q; Wang X; Ding W; Zhao J; Ren G
    BMC Cancer; 2020 Apr; 20(1):344. PubMed ID: 32321471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Minimum Of 100 Tumor Cells in a Single Biopsy Sample Is Required to Assess Programmed Cell Death Ligand 1 Expression in Predicting Patient Response to Nivolumab Treatment in Nonsquamous Non-Small Cell Lung Carcinoma.
    Naito T; Udagawa H; Sato J; Horinouchi H; Murakami S; Goto Y; Kanda S; Fujiwara Y; Yamamoto N; Zenke Y; Kirita K; Matsumoto S; Yoh K; Niho S; Motoi N; Ohe Y; Ishii G; Goto K
    J Thorac Oncol; 2019 Oct; 14(10):1818-1827. PubMed ID: 31260834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of ≥ 50% PD-L1 expression with the SP263 monoclonal antibody in non-small cell lung cancer patients.
    Li W; Song P; Guo L; Liu X; Guo C; Ying J; Gao S
    Thorac Cancer; 2019 Feb; 10(2):175-182. PubMed ID: 30536734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.